Table 3 of Mossböck, Mol Vis 2008; 14:857-861.
Reference | Phenotype | Numbers (cases/controls) | rs1048661 allele G | OR (CI 95%) | rs3825942 allele G | OR (CI 95%) |
Thorleifsson et al. [10] Iceland | XFG | 75/14474 | 0.827 | 2.56 (1.74–3.77) | 0.987 | 13.23 (5.59–31.29) |
Thorleifsson et al. [10] Sweden | XFG | 198/199 | 0.834 | 2.39 (1.72–3.34) | 0.995 | 27.28 (11.44–65.07) |
Fingert et al. [15] USA | XFS | 72/75 | 0.819 | 3.03 (1.78–5.15) | 0.986 | 9.68 (2.44–38.15) |
Hayashi et al. [21] Japan | XFG | 27/189 | 0 | - | 1.0 | - |
Hewitt et al. [18] Australia | XFG, XFS | 86/2087 | 0.78 | 1.86 (1.27–2.76) | 0.95 | 3.81 (1.88–9.02) |
Yang et al. [16] USA | XFG | 49/170 | ND | 1.0 | - | |
Challa et al. [19] USA | XFG | 50/235 | 0.787 | 1.86 (1.1–3.15) | 0.939 | 3.05 (1.2–7.76) |
Fan et al. [17] USA | XFG | 141/80* 146/88 ** | 0.84 | 2.06 (1.29–3.3) | 0.99 | 24.77 (7.5–81.83) |
Ramprasad et al. [20] India | XFG,XFS | 52/97 | 0.72 | 1.49 (0.89–2.51) | 0.92 | 4.17 (1.89–9.18) |
Mossböck et al. (This report) Central Europe | XFG | 167/170 | 0.841 | 2.69 (1.59–4.54) | 0.994 | 37.29 (6.35–218.02) |